HumeCare+ Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: GLP-1 weight loss with real-time body-composition tracking to protect muscle
HumeCare+ scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
HumeCare+ is the GLP-1 telehealth program from Hume Health, the body-composition scale company. It pairs clinician-prescribed compounded semaglutide with continuous body-composition tracking via an included Hume Pod device, so you can see whether you are losing fat rather than muscle. Semaglutide is $199/mo and tirzepatide $299/mo, flat at every dose, billed monthly and cancelable anytime — though no price appears on the marketing site until you finish the intake quiz. The state list, prescribing medical group and pharmacy partner are not named.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
HumeCare+ at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored HumeCare+
Each dimension is scored algorithmically from HumeCare+’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.9/10At $199/mo, HumeCare+ runs about 17% above the $170 median for GLP-1 providers.
Effectiveness25%
8.2/10HumeCare+ offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.5/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.2/10HumeCare+'s exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.0/10HumeCare+ provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this HumeCare+ review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with HumeCare+
We walked HumeCare+’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a free ~1-minute online assessment.
- 2A protocol is customized based on your results, with a USA clinician on your team.
- 3Medication is delivered to your home.
- No monthly price is shown up front; pricing is revealed after completing the assessment (opacity before intake).
- Offers a 'lose 10% body weight or get your money back' guarantee within 6 months (full terms on their terms page).
- Subscription can be canceled anytime.
- Advertises free next-day delivery and unlimited 24/7 access to clinicians.
HumeCare+ customer support
- support@humecare.com
GLP-1 medications HumeCare+ offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Flat $199/mo at every dose (anchor price $299); once-weekly injection. Includes medication, provider consultation and the Hume Pod device
Flat $199/mo at every dose (anchor price $299); pill form
Flat $299/mo at every dose (anchor price $399); sold only as the B12 + glycine combination, with no plain tirzepatide line
Ready to get started?
Plans and promotions change often — check HumeCare+'s current pricing and active discounts before you decide.
What we like
- Pairs compounded semaglutide with continuous body-composition tracking (lose fat, preserve muscle)
- Includes a Hume Pod body-composition device at no extra cost
- $199/mo semaglutide and $299/mo tirzepatide, flat at every dose — no step-up as you titrate
- Backed by Hume Health, an established body-composition scale brand
- Clinician-prescribed and monitored with weekly tracking
Watch-outs
- No price appears on the marketing site; you must finish the intake quiz and give your name before one is quoted
- Tirzepatide is sold only as a B12 + glycine combination — there is no plain tirzepatide option
- Prescribing medical group and pharmacy partner not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Is HumeCare+ worth it? Our verdict
HumeCare+ positions itself around one thing: GLP-1 weight loss with real-time body-composition tracking to protect muscle. It runs $199/month — a premium to the category, so the extras need to justify it.
Beyond the core GLP-1 program, HumeCare+ leans on GLP-1 + body tracking, Hume Pod included, and Cancel anytime.
How much HumeCare+ actually costs
- Compounded semaglutide — $199/month
- Compounded semaglutide — $199/month
- Compounded tirzepatide — $299/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so HumeCare+'s standing rate sits at the premium end.
For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against HumeCare+ before you commit.
Medications: what HumeCare+ prescribes
HumeCare+ prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who HumeCare+ is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
HumeCare+ costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
HumeCare+ scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with HumeCare+?
Starting at $199/month. See current pricing and start your free consultation.
HumeCare+ might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Alternatives to HumeCare+
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this HumeCare+ review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See HumeCare+'s current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.